v3.26.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Jun. 30, 2026
Summary of Significant Accounting Policies  
Schedule of vendor concentration risk percentage

Year Ended

 

June 30, 

 

2026

  ​

  ​

2025

Vendor A

28

%

27

%

Vendor B

11

%

10

%

Schedule of revenue by geographical region

Year Ended

June 30, 

2026

 

2025

United States

$

27,231,305

  ​ ​ ​

56.4

%  

$

28,213,701

57.5

%

Europe

 

15,942,672

 

33.0

%  

 

15,689,693

 

32.0

%

Rest of World

 

5,132,980

 

10.6

%  

 

5,154,587

 

10.5

%

Total

$

48,306,957

 

100

%  

$

49,057,981

 

100

%

Schedule of accounts receivable net by geographical region

Year Ended

 

June 30, 

 

2026

 

2025

United States

  ​ ​ ​

$

3,822,084

  ​ ​ ​

54.9

%  

$

4,033,807

56.1

%

Europe

 

2,226,167

 

32.0

%  

 

2,413,906

 

33.6

%

Rest of World

 

914,789

 

13.1

%  

 

743,521

 

10.3

%

Total

$

6,963,040

 

100

%  

$

7,191,234

 

100

%

Schedule of segment reporting information

Year ended June 30,

2026

  ​ ​ ​

2025

Revenue

$

48,306,957

$

49,057,981

Cost of revenue

 

23,236,449

 

24,862,030

Gross profit

 

25,070,508

 

24,195,951

Gross profit margin

 

51.9%

 

49.3%

Selling, general and administrative expenses:

 

Sales and marketing

6,397,899

5,360,356

Technology and product development

 

6,121,647

 

5,631,344

General and administrative

 

6,724,399

 

7,936,644

Stock-based compensation expense

 

928,516

 

1,723,561

Foreign currency transaction loss (gain)

 

54,697

 

(202,527)

Total selling, general and administrative expenses

 

20,227,158

 

20,449,378

Depreciation and amortization

1,254,973

1,245,362

Net income

$

2,822,068

$

1,265,553

Year ended June 30,

2026

  ​ ​ ​

2025

Cash and cash equivalents

$

12,630,283

  ​ ​ ​

$

12,227,312

Current assets, excluding cash and cash equivalents

 

8,063,885

 

7,772,416

Long term assets

 

24,970,550

 

26,120,946

Total segment assets

$

45,664,718

 

$

46,120,674

Schedule of basic and diluted earnings per share

Years Ended

June 30,

  ​ ​ ​

  ​ ​ ​

2026

  ​ ​ ​

2025

Net income available to common shareholders

$

2,822,068

$

1,265,553

Weighted average commons shares - basic

 

31,788,992

 

30,681,187

Dilutive effect of outstanding stock options

 

465,981

 

822,785

Dilutive effect of unvested restricted common stock

 

17,862

 

Weighted average commons shares - diluted

 

32,272,835

 

31,503,972

Net income per common share:

 

Basic

$

0.09

$

0.04

Diluted

$

0.09

$

0.04

Schedule of Company's assets and liabilities at fair value

As of June 30, 2026

As of June 30, 2025

  ​ ​ ​

Level 1

  ​ ​ ​

Level 2

  ​ ​ ​

Level 3

  ​ ​ ​

Total

  ​ ​ ​

Level 1

  ​ ​ ​

Level 2

  ​ ​ ​

Level 3

  ​ ​ ​

Total

 

  ​

 

  ​

 

  ​

 

  ​

 

  ​

 

  ​

 

  ​

 

  ​

Assets

Total assets

$

$

$

 

$

$

$

$

 

$

Liabilities

Contingent earnout liability

$

$

7,323,314

$

7,323,314

$

$

14,046,640

$

14,046,640

Total liabilities

$

$

$

7,323,314

 

$

7,323,314

$

$

$

14,046,640

 

$

14,046,640

Schedule of company's contingent earnout liability activity

Years Ended

June 30,

  ​ ​ ​

2026

  ​ ​ ​

2025

Beginning balance, contingent earnout liability

$

14,046,640

$

12,298,114

Change in fair value of contingent earnout liability

 

 

1,748,526

Accreted interest expense

 

1,040,293

 

Scite earnout payments in cash

 

(4,856,763)

 

Scite earnout payments in shares of common stock

 

(2,906,856)

 

Ending balance, contingent earnout liability

$

7,323,314

$

14,046,640